*Apologies for cross-posting*
Dear colleagues,
Please consider submitting a paper to our panel “Chronic Living through
pharmaceuticals” in the upcoming *Chronic Living Conference* in Copenhagen,
on 23-25th April 2020.
The deadline for submissions is 1st November 2019
Panel members: Rafaela Zorzanelli (University of Rio de Janeiro) and
Annette Leibing (University of Montreal) (orgs.), Silke Schicktanz
(University of Götingen) and Stefan Ecks (University of Edinburgh)
This is the link to the conference:
https://eventsignup.ku.dk/Chronic-Living
And here is the link to our panel:
https://medialib.cmcdn.dk/medialibrary/95F5D237-C347-4D4B-BBA7-BEA53D7AB316/DEB97370-62D5-E911-8436-00155D0B0940.pdf
Abstract:
Chronic living – the entanglement of life and chronic disease – is tightly
linked to the use of pharmaceuticals. Medications prescribed for well-known
chronic conditions such as diabetes and heart disease–but also for illnesses
whose diagnoses are contested, such as chronic fatigue syndrome and
electrosensitivity – turn the goal of biomedical treatment from healing to
chronic living. Even when chronic living means for the most part the
managing and rearranging of habits and lifestyles, pharmaceuticals are
often involved, although this kind of involvement needs to be situated – it
depends on epistemic cultures, types of health and social system, lobbying
mechanisms, among other factors. Pharmaceuticals in many cases allow for a
better life with chronic illness; however, the shaping of diagnostic and
evaluation criteria, the promotion of pre-diseases, as well as medicines
for asymptomatic and “at-risk” individuals sometimes influenced by economic
interests of the pharmaceutical industry can also make people more likely
to be classified as a chronically ill patient. The role of pharmaceuticals
in the equation is therefore ambiguous and complex, and in need of more
in-depth studies with respect to local and global mechanisms affecting
chronic living. This panel consists of four papers in which chronic living
through pharmaceuticals is analyzed as (a) The chronic use of tranquilizers
in Rio de Janeiro, Brazil (RZ); (b) Geriatric dementia care enacted as
“fine-tuning” in Brazil (AL et al.); (c) Social and ethical issues of
pharmacogenetics and stratified oncology treatment in colon cancer patients
(SiSc); and (d) Depression, the acceleration of time, and the fatigue of
the self in India and elsewhere (SE).
Warm regards,
Rafaela Zorzanelli and Annette Leibing
*************************************************************
* Anthropology-Matters Mailing List
* http://www.anthropologymatters.com *
* A postgraduate project comprising online journal, *
* online discussions, teaching and research resources *
* and international contacts directory. *
* To join this list or to look at the archived previous *
* messages visit: *
* https://www.jiscmail.ac.uk/Anthropology-Matters *
* If you have ALREADY subscribed: to send a message to all *
* those currently subscribed to the list,just send mail to: *
* [log in to unmask] *
* *
* Enjoyed the mailing list? Why not join the new *
* CONTACTS SECTION @ www.anthropologymatters.com *
* an international directory of anthropology researchers *
To unsubscribe please click here:
https://www.jiscmail.ac.uk/cgi-bin/webadmin?SUBED1=ANTHROPOLOGY-MATTERS&A=1
***************************************************************
|
